110 related articles for article (PubMed ID: 7497456)
41. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
[TBL] [Abstract][Full Text] [Related]
42. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
Wang Y; He QY; Chen H; Chiu JF
Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
[TBL] [Abstract][Full Text] [Related]
43. [Biochemical mechanism of raloxifen and tamoxifen action for the prevention of breast cancer. Studies in vitro].
Wołczyński S; Swiatecka J; Anchim T; Dabrowska M; Dziecioł J
Ginekol Pol; 2000 Sep; 71(9):1147-52. PubMed ID: 11082993
[TBL] [Abstract][Full Text] [Related]
44. Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.
Qi W; Sun M; Kong X; Li Y; Wang X; Lv S; Ding X; Gao S; Cun J; Cai C; Wang X; Chen J; Yin A; Yang Q
Oncotarget; 2016 May; 7(18):26003-15. PubMed ID: 27027343
[TBL] [Abstract][Full Text] [Related]
45. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
[TBL] [Abstract][Full Text] [Related]
46. Calmodulin enhances the stability of the estrogen receptor.
Li Z; Joyal JL; Sacks DB
J Biol Chem; 2001 May; 276(20):17354-60. PubMed ID: 11278648
[TBL] [Abstract][Full Text] [Related]
47. Role of calmodulin in HIV-potentiated Fas-mediated apoptosis.
Pan Z; Radding W; Zhou T; Hunter E; Mountz J; McDonald JM
Am J Pathol; 1996 Sep; 149(3):903-10. PubMed ID: 8780394
[TBL] [Abstract][Full Text] [Related]
48. The voltage- and time-dependent blocking effect of trifluoperazine on T lymphocyte Kv1.3 channels.
Teisseyre A; Michalak K
Biochem Pharmacol; 2003 Feb; 65(4):551-61. PubMed ID: 12566082
[TBL] [Abstract][Full Text] [Related]
49. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
Balça-Silva J; Matias D; do Carmo A; Girão H; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC
Biochim Biophys Acta; 2015 Apr; 1850(4):722-32. PubMed ID: 25554223
[TBL] [Abstract][Full Text] [Related]
50. Calmodulin antagonists elevate the levels of 32P-labeled polyphosphoinositides in human platelets.
Tallant EA; Wallace RW
Biochem Biophys Res Commun; 1985 Aug; 131(1):370-7. PubMed ID: 2994657
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of T-cell invasion across cultured fibroblast monolayers by phenothiazine-related calmodulin inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of the monolayer by pimozide.
Grabski R; Dewit J; De Braekeleer J; Malicka-Blaskiewicz M; De Baetselier P; Verschueren H
Biochem Pharmacol; 2001 May; 61(10):1313-7. PubMed ID: 11322935
[TBL] [Abstract][Full Text] [Related]
52. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.
Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW
Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855
[TBL] [Abstract][Full Text] [Related]
53. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?
Gelmann EP
J Natl Cancer Inst; 1996 Mar; 88(5):224-6. PubMed ID: 8613997
[No Abstract] [Full Text] [Related]
54. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
[TBL] [Abstract][Full Text] [Related]
55. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells.
Lagadec C; Adriaenssens E; Toillon RA; Chopin V; Romon R; Van Coppenolle F; Hondermarck H; Le Bourhis X
Oncogene; 2008 Feb; 27(10):1472-7. PubMed ID: 17767197
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination.
Guthrie N; Gapor A; Chambers AF; Carroll KK
J Nutr; 1997 Mar; 127(3):544S-548S. PubMed ID: 9082043
[TBL] [Abstract][Full Text] [Related]
57. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.
Fancy RM; Kim H; Napier T; Buchsbaum DJ; Zinn KR; Song Y
J Cell Biochem; 2018 Jul; 119(7):6216-6230. PubMed ID: 29663486
[TBL] [Abstract][Full Text] [Related]
58. Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D; Schmidt H
Biochem Pharmacol; 1986 Feb; 35(4):673-8. PubMed ID: 3947398
[TBL] [Abstract][Full Text] [Related]
59. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
Barron E; Marshall RJ; Martorana M; Winslow E
Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
[TBL] [Abstract][Full Text] [Related]
60. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
